🔒 Palantir secures £330 million NHS contract amid trust concerns and controversy
Palantir Technologies secures a seven-year, £330 million contract to revamp the NHS’s patient-data system, following controversial ties and skepticism.
Palantir Technologies secures a seven-year, £330 million contract to revamp the NHS’s patient-data system, following controversial ties and skepticism.
As the UK’s NHS celebrates its 75th anniversary, Andrew Kenny reflects on his personal experiences with the NHS and questions its effectiveness.
As the UK looks to move towards a mixed, decentralised NHS system, SA pushes for healthcare centralisation.
At least a thousand families allege their children were rushed into taking life-changing puberty blocking drugs by the UK’s only children’s gender identity development service.
The Sunday Times of London recently explored the dangers of over-prescription and the undervaluing of alternative therapies to medication.
“Third, unexpected rise during pandemic raises possibilities of fatalities caused by NHS strains and lack of early diagnosis,” reports the Financial Times.
“Data on benefits from the jab come as NHS is told to draw up plans to vaccinate children aged 12-15”, writes The Financial Times.
Simon Lincoln Reader reflects on a year of Covid-19 lockdown. “The whole point of this thing – life – was to live amongst, not away from”, he writes.
Professor Alan Whiteside assesses the Covid-19 pandemic, one year on, in an unequal world where vaccines are still a subject of great debate.
The UK is the first country to approve the AstraZeneca-Oxford Covid-19 vaccine for use in its national inoculation programme.